Special items: Ovarian Cancer and Us blog best viewed in Firefox

Thursday, February 18, 2010

Quest, Vermillion 'On Track' to Launch OVA1 in March | GenomeWeb

"OVA1 generates a numerical score based on five immunoassays that is intended to help physicians determine the likelihood of malignancy in women with pelvic mass for whom surgery is planned."

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.